Logo image of ALSPT.PA

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

EPA:ALSPT - FR00140043Y1 - Common Stock

0.388 EUR
0 (-1.02%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

3

ALSPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 51 industry peers in the Specialty Retail industry. ALSPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALSPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALSPT has reported negative net income.
ALSPT had a positive operating cash flow in the past year.
In multiple years ALSPT reported negative net income over the last 5 years.
In multiple years ALSPT reported negative operating cash flow during the last 5 years.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.62%, ALSPT is doing worse than 64.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of -7.89%, ALSPT is doing worse than 66.67% of the companies in the same industry.
The Return On Invested Capital of ALSPT (7.75%) is better than 72.55% of its industry peers.
Industry RankSector Rank
ROA -2.62%
ROE -7.89%
ROIC 7.75%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

ALSPT has a better Operating Margin (3.72%) than 62.75% of its industry peers.
ALSPT's Operating Margin has improved in the last couple of years.
The Gross Margin of ALSPT (50.88%) is better than 76.47% of its industry peers.
ALSPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) N/A
GM 50.88%
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALSPT is creating some value.
Compared to 1 year ago, ALSPT has more shares outstanding
ALSPT has a better debt/assets ratio than last year.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ALSPT has an Altman-Z score of 1.70. This is a bad value and indicates that ALSPT is not financially healthy and even has some risk of bankruptcy.
ALSPT has a Altman-Z score of 1.70. This is comparable to the rest of the industry: ALSPT outperforms 45.10% of its industry peers.
The Debt to FCF ratio of ALSPT is 3.41, which is a good value as it means it would take ALSPT, 3.41 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.41, ALSPT is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that ALSPT is somewhat dependend on debt financing.
ALSPT has a Debt to Equity ratio of 0.50. This is comparable to the rest of the industry: ALSPT outperforms 49.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.41
Altman-Z 1.7
ROIC/WACC1.35
WACC5.74%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.83 indicates that ALSPT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.83, ALSPT belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
ALSPT has a Quick Ratio of 1.83. This is a bad value and indicates that ALSPT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALSPT's Quick ratio of 0.70 is fine compared to the rest of the industry. ALSPT outperforms 62.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 0.7
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

ALSPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.17%.
Looking at the last year, ALSPT shows a decrease in Revenue. The Revenue has decreased by -8.71% in the last year.
Measured over the past years, ALSPT shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1334.69%
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-6.86%

3.2 Future

The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
Based on estimates for the next years, ALSPT will show a decrease in Revenue. The Revenue will decrease by -0.51% on average per year.
EPS Next Y-150%
EPS Next 2Y73.21%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-4.74%
Revenue Next 2Y-1.1%
Revenue Next 3Y-0.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ALSPT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALSPT is cheaper than 100.00% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than ALSPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.16
EV/EBITDA 1.02
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y0%

0

5. Dividend

5.1 Amount

No dividends for ALSPT!.
Industry RankSector Rank
Dividend Yield N/A

SPARTOO

EPA:ALSPT (9/2/2025, 7:00:00 PM)

0.388

0 (-1.02%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.09M
Analysts82
Price Target0.82 (111.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.16
P/OCF 1.08
P/B 0.24
P/tB 0.29
EV/EBITDA 1.02
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0.33
FCFY86%
OCF(TTM)0.36
OCFY92.59%
SpS7.14
BVpS1.62
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -7.89%
ROCE 10.54%
ROIC 7.75%
ROICexc 11.61%
ROICexgc 13.8%
OM 3.72%
PM (TTM) N/A
GM 50.88%
FCFM 4.68%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y13.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y13.21%
ROICexc growth 5YN/A
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score3
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.41
Debt/EBITDA 1.18
Cap/Depr 6.11%
Cap/Sales 0.36%
Interest Coverage 250
Cash Conversion 52.52%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 0.7
Altman-Z 1.7
F-Score3
WACC5.74%
ROIC/WACC1.35
Cap/Depr(3y)16.79%
Cap/Depr(5y)31.52%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1334.69%
EPS Next Y-150%
EPS Next 2Y73.21%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-6.86%
Revenue Next Year-4.74%
Revenue Next 2Y-1.1%
Revenue Next 3Y-0.51%
Revenue Next 5YN/A
EBIT growth 1Y59.21%
EBIT growth 3Y20.46%
EBIT growth 5YN/A
EBIT Next Year315.84%
EBIT Next 3Y72.78%
EBIT Next 5YN/A
FCF growth 1Y84.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.49%
OCF growth 3YN/A
OCF growth 5YN/A